I was quite encouraged by the NTII call, I
wont hype it here, coz if Memantine doesn't
work, who cares, at this stage NTI is just
another microcap biotech stock, and having
to trade on the pink sheets doesn't help.
However....even if the odds are stacked
against it, as they are against all biotech
companies, simply having a compound in Phase
II means that the market cap of NTI is way
too low--especially when there is a slight
chance that Mementine could have applicaitons
for treating, or at least slowing down the
progression of Alzheimers.
My next post will be on the effects of compounding,
and how all these mutual funds who show graphs of
how compounding will make you rich, are full of
crap--they are misleading people. My answer to why
this is so will be my next post.
By the way, does anybody read this thread? If so
I'd appreciate a private message, if I don't receive
any over the next week maybe I'll just shut this
thing down, I must look like an idiot talking to
myself here, and besides, what does a 31 year old
weather forecaster know about biotech and risky investing
anyway!
(answer: Probably not enough to be throwing money at them!) |
